23-02-2010: Ehrfeld Mikrotechnik BTS (EMB), a Bayer Technology Services company, and Lonza signed a worldwide manufacturing and distribution license agreement together with a cooperation and development agreement on the Lonza microreactor technology. Under the terms of the agreements, EMB will acquire a license from Lonza on two key products: the Lonza Development Microreactor (process development) and the Lonza Advanced Production Microreactors (manufacturing). As a result, EMB will become the exclusive worldwide manufacturer, vendor, and distributor of Lonza microreactors. Lonza microreactors are the most advanced reactor technology for numerous chemical syntheses based on micro-structured devices. Lonza and EMB also agree to further develop the product via the cooperation and development agreement.
“Both agreements are strategic for Lonza as they will broaden the base of users to freely utilize this cutting-edge reactor technology to develop the greener and sustainable processes of tomorrow”, says Dominique Roberge, Head of Microreactor Technology Business Development. “We are excited to continue to develop the Microreactor Technology and to strengthen the leading position of Lonza in this field”.
“This cooperation is an excellent strategic fit for us to extend our outstanding microreaction technology portfolio with proven technology and know-how to serve our customers world wide,” says Dr. Olaf Stange Managing Director of EMB. “Together with Lonza and our key experts at Bayer Technology Services we are looking forward to becoming the leading supplier and consultant in the field of microreaction technology.”
Watchlist
This is where you can add this news to your personal favourites
2012 was a very successful year for the Bayer Group. “We continued to grow dynamically and achieved our targets for the Group. All the subgroups posted gains in sales and earnings before special items,” said Bayer CEO Dr. Marijn Dekkers at the Financial News Conference in Leverkusen on Thur ... more
The Alexander von Humboldt Foundation and the Bayer Science & Education Foundation will soon be awarding joint research fellowships. Until 2018, the Bayer Foundation will be making around three million EUR available to fund approximately ten Humboldt-Bayer Research Fellowships annually. The ... more
The winners of the Bayer Early Excellence in Science Award 2012 have been announced. The prizes, each worth EUR 10,000, have been awarded by an independent scientific committee of the Bayer Science & Education Foundation. The Bayer foundation presents for the fourth time the Bayer Early Exc ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more
Lonza Ltd and Novoset LLC announce the introduction of a new generation of thermoset polyimides. The new polyimides address shortcomings of conventional high temperature polyimides currently available in the market and will serve semiconductor packaging, aerospace, abrasives, composite tool ... more
Lonza Group Ltd announced that LG Acquisition Corp., an indirect wholly owned subsidiary of Lonza, has extended the expiration date for its previously announced tender offer for 100 percent of the outstanding shares of common stock of Arch Chemicals, Inc.. The tender offer is at a price of ... more
Lonza Group Ltd and Arch Chemicals, Inc. announced that they have signed an agreement pursuant to which Lonza has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash.
Lonza’s offer represents a 36. ... more
Lonza Ibérica is responsible for the sales and market development of Fine Chemicals, Biocides, Vitamines and other Exclusive products cGMP or not in Spain and Portugal.
Moreover, some of our business is in the area of Custom Synthesis for Life Science companies. Lonza Ibérica works as our c ... more
Dr. Joachim Heck will succeed Dr. Olaf Stange as Managing Director of Ehrfeld Mikrotechnik BTS GmbH effective March 1, 2010. Stange will become the head of the new Southeast Asia regional office of Bayer Technology Services (BTS) in Singapore effective that same date.
After earning his deg ... more
Ehrfeld Mikrotechnik BTS (EMB), a Bayer Technology Services company, and Lonza signed a worldwide manufacturing and distribution license agreement together with a cooperation and development agreement on the Lonza microreactor technology. Under the terms of the agreements, EMB will acquire ... more